Indefinite Delivery Contract 75D30120D08575
Award Date
7/1/20
Last Date to Order
6/30/21
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention (CDC) has awarded Pfizer Inc. an Indefinite Delivery Contract (IDC) for the supply of various adult vaccines to support immunization programs under Section 317(j) of the Public Health Service Act. The $103,060,230.33 contract, which runs from July 1, 2023 to June 30, 2024, covers a range of vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles-mumps-rubella, meningococcal...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc., a large pharmaceutical manufacturer. The $102,613,000 contract is for the delivery of 13 standard adult vaccines, including hepatitis, pneumococcal, tetanus, herpes zoster, measles/mumps/rubella, meningococcal, human papillomavirus, and varicella vaccines. Vaccines must have a minimum 12-month shelf life and be delivered within 15 business days...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. for the purchase of various adult vaccines. The $118.2 million contract, running from July 1, 2024 to June 30, 2025, covers a diverse array of vaccines including Hepatitis, HPV, Measles/Mumps/Rubella, Meningococcal, Mpox, Pneumococcal, and Varicella. The contract does not utilize any set-asides and allows for...
This federal contract IDV award is a multiple-award Indefinite Delivery Contract between the Centers for Disease Control and Prevention (CDC) and Pfizer Inc., a global pharmaceutical manufacturer. The $117,849,500 contract, with a performance period ending June 30, 2026, is for the delivery of adult vaccines under the CDC's VACCINES program. As the prime contractor, Pfizer will provide a range of pharmaceutical products to multiple federal healthcare agencies, including the Department of...
This Indefinite Delivery Contract (IDC) award from the Centers for Disease Control and Prevention (CDC) is for the procurement of 12 standard adult vaccines to support state health department immunization programs. The $62,183,800 multiple-award contract has a period of performance from July 1, 2022 to June 30, 2023. The prime contractor is Pfizer Inc., a large pharmaceutical manufacturer that serves as a major federal supplier of medical products and vaccines. The contract requires the delivery...
The Centers for Disease Control and Prevention awarded multiple indefinite-delivery, indefinite-quantity contracts valued at up to $25,350,000 to supply adult vaccines for the period of July 1, 2023 through June 30, 2024. The prime contractor is VBI Vaccines (Delaware) Inc. The contracts aim to procure minimum and maximum quantities of 12 adult vaccines, including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles, mumps and rubella,...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024. The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under a competitive solicitation to purchase standard adult vaccines. The contracts have a one year period of performance from July 1, 2022 to June 30, 2023 and a combined potential value of $85.6 million. Merck Sharp & Dohme LLC was awarded one of these contracts as the prime contractor. The contracts enable the CDC to order 12 types of adult vaccines for delivery within 15 business days....
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc., a large pharmaceutical manufacturer, to support the Vaccines for Children (VFC) program. The $2,208,581,100 contract, which spans April 1, 2025 through March 30, 2026, will provide a range of standard commercial pediatric vaccines to eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. as the prime contractor. The contract has a ceiling value of $1,517,947,500.00 and a period of performance from April 1, 2022 through March 31, 2023. It is a multiple award contract vehicle that will provide up to 23 standard pediatric vaccines to support CDC's Immunization Awardees and the Vaccines for...